Health Care Reform and the Pharmaceutical Industry: A Global Discussion
In the US and abroad, rising medical costs have increased the conversation on health care reform everywhere from the boardroom to the kitchen table.
For too long, there has been an unfortunate perception that pharmaceuticals are a negative factor in the health care cost equation. Globally, drug therapy will be an increasingly important part in supporting access to health care as the population ages and life threatening and disabling diseases continue to be prevalent. An increasingly mobile world will also rely heavily on the technology of vaccine and drug development capability to rapidly respond to potential pandemics and other widespread diseases. To prepare for these changes, both private industry and political representatives must consider the tradeoffs of measures that impact the industry’s capacity for scientific advancement and economic benefit as they seek cost control.
READ MORE